research chemical comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-25. Numbers and descriptions here follow the published literature rather than marketing material.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Generally all gingival diseases share common features such as signs and symptoms being restricted to gingiva, clinically detectable inflammation, and the potential for the gum tissues to return to a state of health once the cause is removed, without irreversible loss of attachment of the teeth.
== Bibliography == Boyd Orr, John (1905). Scotch Church Crisis: The Full Story of the Modern Phase of the Presbyterian Struggle. Glasgow: John M'Neilage. —————— (1929). Minerals in Pastures and Their Relation to Animal Nutrition. London: Lewis. —————— (1934). The National Food Supply and Its Influence on Public Health. London: King. —————— (1936). Food, Health and Income. London: Macmillan. —————— (1937). Nutritional Science and State Planning.in (Orr) —————— (1940). Nutrition in war. Fabian Tract 251. London: Fabian Society. —————— (1942). Fighting for What?. London: Macmillan. —————— (1943). Food and the People. London: Pilot Press. —————— (1945). Welfare and Peace. London: National Peace Council. —————— (1946). A Charter for Health. London: Allen & Unwin. —————— (1948). Food: The Foundation of World Unity. London: National Peace Council. —————— (1950). International Liaison Committee of Organisations for Peace: A New Strategy of Peace. London: National Peace Council. —————— (1957). Feast and famine: The wonderful world of food. London: Rathbone Books. —————— (1958). The Wonderful World of Food: The Substance of Life. Garden City, NY: Garden City Books. —————— (1966). As I recall: the 1880s to the 1960s. with an introduction by Ritchie Calder. London: MacGibbon & Kee. with other authors Boyd Orr, John; Lubbock, David (1940). Feeding the people in war time. London: Macmillan – via Internet Archive. Boyd Orr, John; Lubbock, David (1964) [First published 1953]. The White Man's Dilemma: Food and the Future (2nd ed.). London: Allen & Unwin. Boyd Orr, John (1968).
May 21, 1992: Decree concerning the responsibilities of the Secretary of State for Women's Rights and Consumer Affairs. July 22, 1992: Law reforming the provisions of the Penal Code relating to the repression of crimes and offenses against persons. November 2, 1992: Law concerning abuse of authority in sexual matters in work relationships and amending the Labour Code and the Code of Criminal Procedure. January 8, 1992: Law amending the Civil Code concerning civil status, family, and children's rights, and establishing the family affairs judge. January 27, 1993: Law concerning various social measures, notably establishing the offense of obstructing abortion and decriminalizing self-induced abortion. April 8, 1993: Decree concerning the responsibilities of the Minister of State, Minister of Social Affairs, Health, and the City. July 22, 1993: Law reforming nationality law. August 2, 1993: Law concerning the control of immigration and the conditions of entry, reception, and residence of foreigners in France. April 21, 1994: Discussion on the possibility of quotas and potential gender parity in the exercise of responsibilities, particularly political ones. July 15, 1994: Law concerning the family. July 29, 1994: Law concerning respect for the human body. July 29, 1994: Law concerning the donation and use of elements and products of the human body, medically assisted procreation, and prenatal diagnosis. June 1, 1995: Decree concerning the responsibilities of the Minister for Intergenerational Solidarity. October 18, 1995: Creation of the Observatory for Gender Parity.
Sources: en.wikipedia.org
With regard to adverse drug reactions, there is data from animal studies that "long-term administration of human growth hormone can increase the risk of diabetes, retention of fluids, joint and muscle pain, hypertension, cardiomyopathy, osteoporosis, irregular menstruation, impotence and elevated HDL cholesterol." A report from the United States House Committee on Oversight and Government Reform on steroid and growth hormone use found that the misguided use of HGH by professional athletes and entertainers was fuelling the industry peddling the drug to the general public for medically inappropriate uses.
== Southern Rhodesians in other theatres == In addition to the main deployments, Southern Rhodesian servicemen served in other theatres of the war. Rhodesian sailors in the Royal, South African and Merchant Navies crewed ships in many parts of the world, including the Indian Ocean, the Arctic and the Pacific. No. 237 (Rhodesia) Squadron operated in Iran and Iraq in 1942–43, guarding oil wells and pipelines and supporting the British Tenth Army. Closer to home, Southern Rhodesian military surveyors contributed to the preliminary planning work for the Allied invasion of Madagascar in May 1942, and landed at Diego Suarez with the invading forces. They remained there long after the Vichy French garrison agreed to an armistice at Ambalavao on 6 November 1942—the last Rhodesian left the island in October 1943.
== Terminology == The term "fibromyalgia" was derived from Neo-Latin fibro- (meaning 'fibrous tissues'), Greek μυο- (myo-, 'muscle'), and Greek άλγος (algos, 'pain'). Thus, the term literally means "muscle and fibrous connective tissue pain". Thus, this term is inaccurate and misleading, as it only reflects a part of the symptom set. The term "FM" is increasingly used.
Sources: en.wikipedia.org
=== Other === Around 30% of people have swollen, painful joints, but this is generally mild. Later in the course of the disease, patients often experience difficulty swallowing, called dysphagia, which makes it hard to move food from the mouth to the stomach. The muscles of the esophagus may become weak, leading to reduced or irregular movements that prevent proper swallowing. Additionally, individuals might suffer from gastroesophageal reflux disease (GERD), where stomach acid flows back into the esophagus, causing heartburn and irritation.
The minus sign comes from the convention that the force is considered towards the surface element, while the normal vector points outward. The equation has meaning in that, for any surface S in contact with the fluid, the total force exerted by the fluid on that surface is the surface integral over S of the right-hand side of the above equation. It is incorrect (although rather usual) to say "the pressure is directed in such or such direction". The pressure, as a scalar, has no direction. The force given by the previous relationship to the quantity has a direction, but the pressure does not. If we change the orientation of the surface element, the direction of the normal force changes accordingly, but the pressure remains the same. Pressure is distributed to solid boundaries or across arbitrary sections of fluid normal to these boundaries or sections at every point. It is a fundamental parameter in thermodynamics, and it is conjugate to volume. It is defined as a derivative of the internal energy of a system:
"In 1971 I stressed protein complementarity because I assumed that the only way to get enough protein ... was to create a protein as usable by the body as animal protein. In combating the myth that meat is the only way to get high-quality protein, I reinforced another myth. I gave the impression that in order to get enough protein without meat, considerable care was needed in choosing foods. Actually, it is much easier than I thought. "With three important exceptions, there is little danger of protein deficiency in a plant food diet. The exceptions are diets very heavily dependent on [1] fruit or on [2] some tubers, such as sweet potatoes or cassava, or on [3] junk food (refined flours, sugars, and fat). Fortunately, relatively few people in the world try to survive on diets in which these foods are virtually the sole source of calories. In all other diets, if people are getting enough calories, they are virtually certain of getting enough protein." The necessity of protein combining was not asserted. Rather, the increased biological value of meals where proteins are combined was noted. In a concession, Lappé removed from the second edition "charts that indicate exact proportions of complementary proteins". The American Dietetic Association reversed itself in its 1988 position paper on vegetarianism. Suzanne Havala, the primary author of the paper, recalls the research process:
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.